Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

SecurityEVH / Evolent Health, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership198,588 shares
Latest Disclosed Value $ 2,236,100
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 2.02% increase in ownership of EVH / Evolent Health, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 198,588 shares of Evolent Health, Inc. (US:EVH) valued at $2,236,101 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 194,653 shares of Evolent Health, Inc.. This represents a change in shares of 2.02% during the quarter. The current value of the position is $838,041 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Evolent Health EC US30050B1017 198,588 3,935 2.02 2,236 21.32 0.0502
2025-05-28 2025-03-31 NP Evolent Health EC US30050B1017 194,653 0 0.00 1,843 -15.81 0.0442
2025-02-25 2024-12-31 NP Evolent Health EC US30050B1017 194,653 -31,913 -14.09 2,190 -65.83 0.0478
2024-11-26 2024-09-30 NP Evolent Health EC US30050B1017 226,566 12,682 5.93 6,407 56.69 0.1212
2024-08-26 2024-06-30 NP Evolent Health EC US30050B1017 213,884 19,379 9.96 4,089 -35.88 0.0833
2024-05-28 2024-03-31 NP Evolent Health EC US30050B1017 194,505 -6,099 -3.04 6,378 -3.74 0.1331
2024-02-26 2023-12-31 NP Evolent Health EC US30050B1017 200,604 13,784 7.38 6,626 30.23 0.1414
2023-11-28 2023-09-30 NP Evolent Health EC US30050B1017 186,820 -3,265 -1.72 5,087 -11.67 0.1327
2023-08-25 2023-06-30 NP Evolent Health EC US30050B1017 190,085 59,210 45.24 5,760 35.63 0.1366
2023-05-26 2023-03-31 NP Evolent Health EC US30050B1017 130,875 1,530 1.18 4,247 16.91 0.1131
2023-02-24 2022-12-31 NP Evolent Health EC US30050B1017 129,345 -773 -0.59 3,632 -22.31 0.0999
2022-11-25 2022-09-30 NP Evolent Health EC US30050B1017 130,118 2,360 1.85 4,675 19.17 0.1339
2022-08-25 2022-06-30 NP Evolent Health EC US30050B1017 127,758 3,818 3.08 3,923 -2.00 0.1083
2022-05-26 2022-03-31 NP Evolent Health EC US30050B1017 123,940 1,946 1.60 4,003 18.61 0.0933
2022-02-25 2021-12-31 NP Evolent Health EC US30050B1017 121,994 1,669 1.39 3,376 -9.52 0.0732
2021-11-24 2021-09-30 NP Evolent Health EC US30050B1017 120,325 6,001 5.25 3,730 54.52 0.0822
2021-08-26 2021-06-30 NP Evolent Health EC US30050B1017 114,324 0 0.00 2,415 4.55 0.0518
2021-05-27 2021-03-31 NP Evolent Health EC US30050B1017 114,324 -7,143 -5.88 2,309 18.59 0.0524
2021-02-25 2020-12-31 NP Evolent Health EC US30050B1017 121,467 0 0.00 1,947 29.20 0.0499
2020-11-25 2020-09-30 NP Evolent Health EC US30050B1017 121,467 -7,697 -5.96 1,507 63.98 0.0484
2020-08-27 2020-06-30 NP Evolent Health EC US30050B1017 129,164 9,586 8.02 920 41.60 0.0301
2020-06-01 2020-03-31 NP Evolent Health EC US30050B1017 119,578 4,653 4.05 649 -37.60 0.0265
2020-02-27 2019-12-31 NP Evolent Health EC 30050B101 114,925 4,664 4.23 1,040 31.31 0.0313
2019-11-27 2019-09-30 NP Evolent Health EC US30050B1017 110,261 110,261 793 0.0262
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.